Company: AEMD
Filing Date: 2025-08-20
Form Type: S-1
Source: 0001683168-25-006352
Chunk: 49

Company: AETHLON MEDICAL INC
Filing Date: 2025-08-20
Form: S-1
Chunk 49
---
 those Inducement Warrants if such exercise or
conversion would cause the Selling Securityholders, together with certain related parties, to beneficially own a number of shares of common
stock which would exceed 4.99% of our then outstanding common stock following such exercise or conversion, excluding for purposes of such
determination, common stock issuable upon exercise of the Inducement Warrants which have not been exercised.

The table below sets forth, as
of August [__], 2025, the following information regarding the Selling Securityholders:

| · | the name of the Selling Securityholders;                                                                                                                                                                                                                                |
| · | the number of shares of common stock owned by the Selling Securityholders prior to this offering, without regard to any beneficial ownership limitations contained in the Inducement Warrants;                                                                          |
| · | the number of shares of common stock to be offered by the Selling Securityholders in this offering;                                                                                                                                                                     |
| · | the number of shares of common stock to be owned by the Selling Securityholders assuming the sale of all of the shares of common stock covered by this prospectus; and                                                                                                  |
| · | the percentage of our issued and outstanding shares of common stock to be owned by the Selling Securityholders assuming the sale of all of the common stock covered by this prospectus based on the number of shares of common stock issued and outstanding as of [__]. |

Except as described above, the
number of shares of common stock beneficially owned by the Selling Securityholders have been determined in accordance with Rule 13d-3
under the Exchange Act and includes, for such purpose, shares of common stock that the Selling Securityholders have the right to acquire
within 60 days after [__].

Because the Selling Securityholders
identified in the table may sell some or all of the shares of common stock beneficially owned and covered by this prospectus, and because
there are currently no agreements, arrangements or understandings with respect to the sale of any of the shares of common stock, no estimate
can be given as to the number of shares of common stock available for resale hereby that will be held by the Selling Securityholders upon
termination of this offering. In addition, the Selling Securityholders may have sold, transferred or otherwise disposed of, or may sell,
transfer or otherwise dispose of, at any time and from time to time, the shares of common stock they beneficially own in transactions
exempt from the registration requirements of the Securities Act after the date on which they provided the information set forth